| Medical and Health Sciences | Lifetime | 429 | JP 2 | 99.98 |
| Public, Environmental and Occupational Health | Lifetime | 41 | JP 1 | 99.95 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 37 | JP 1 | 99.88 |
| Ophthalmology | Lifetime | 54 | JP 3 | 99.70 |
| Medical Physiology | Lifetime | 972 | JP 8 | 98.14 |
| Dermatology | Lifetime | 520 | JP 27 | 95.85 |
| Immunology and Allergy | Lifetime | 477 | JP 15 | 91.68 |
| Endocrine and Autonomic Systems | Lifetime | 793 | JP 37 | 80.40 |
| Clinical Biochemistry | Lifetime | 830 | JP 26 | 76.49 |
| Public, Environmental and Occupational Health | 2021-2025 | 214 | JP 1 | 98.14 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 172 | JP 2 | 96.72 |
| Epidemiology | 2021-2025 | 436 | JP 12 | 96.21 |
| Ophthalmology | 2021-2025 | 133 | JP 7 | 95.08 |
| Ocular Surface and Contact Lens | Lifetime | 1 | JP 1 | 99.96 |
| Corneal Surgery and Treatments | Lifetime | 1 | JP 1 | 99.95 |
| Corneal surgery and disorders | Lifetime | 3 | JP 1 | 99.93 |
| Glaucoma and retinal disorders | Lifetime | 10 | JP 1 | 99.90 |
| Salivary Gland Disorders and Functions | Lifetime | 8 | JP 1 | 99.68 |
| Ocular Infections and Treatments | Lifetime | 27 | JP 1 | 99.27 |
| Allergic Rhinitis and Sensitization | Lifetime | 106 | JP 2 | 99.46 |
| Ophthalmology and Visual Impairment Studies | Lifetime | 64 | JP 4 | 99.24 |
| Ocular Disorders and Treatments | Lifetime | 19 | JP 2 | 98.41 |
| Retinal Diseases and Treatments | Lifetime | 204 | JP 12 | 99.17 |
| Intraocular Surgery and Lenses | Lifetime | 202 | JP 18 | 98.78 |
| Urticaria and Related Conditions | Lifetime | 145 | JP 11 | 98.48 |
| Olfactory and Sensory Function Studies | Lifetime | 263 | JP 13 | 97.69 |
| Retinal Development and Disorders | Lifetime | 464 | JP 22 | 97.61 |
| Advanced Glycation End Products research | Lifetime | 276 | JP 41 | 96.16 |
| Connexins and lens biology | Lifetime | 243 | JP 15 | 96.48 |
| Dermatology and Skin Diseases | Lifetime | 575 | JP 46 | 97.33 |
| Nasolacrimal Duct Obstruction Treatments | Lifetime | 45 | JP 3 | 95.67 |
| Circadian rhythm and melatonin | Lifetime | 739 | JP 51 | 96.04 |
| Retinopathy of Prematurity Studies | Lifetime | 194 | JP 5 | 95.19 |
| Skin Protection and Aging | Lifetime | 539 | JP 22 | 95.65 |
| Ergonomics and Musculoskeletal Disorders | Lifetime | 453 | JP 6 | 94.41 |
| Medical and Biological Ozone Research | Lifetime | 247 | JP 8 | 91.26 |
| Ophthalmology and Eye Disorders | Lifetime | 925 | JP 51 | 93.73 |
| Contact Dermatitis and Allergies | Lifetime | 882 | JP 31 | 93.87 |
| Sirtuins and Resveratrol in Medicine | Lifetime | 526 | JP 28 | 91.46 |
| Advancements in Transdermal Drug Delivery | Lifetime | 796 | JP 31 | 93.02 |
| Facial Rejuvenation and Surgery Techniques | Lifetime | 695 | JP 19 | 90.03 |
| Aldose Reductase and Taurine | Lifetime | 740 | JP 88 | 85.70 |
| Hydrogen's biological and therapeutic effects | Lifetime | 676 | JP 107 | 75.89 |
| Older Adults Driving Studies | Lifetime | 875 | JP 21 | 75.14 |
| Clusterin in disease pathology | Lifetime | 962 | JP 74 | 42.27 |
| Ocular Surface and Contact Lens | 2021-2025 | 26 | JP 1 | 98.65 |
| Glaucoma and retinal disorders | 2021-2025 | 110 | JP 8 | 98.35 |
| Corneal surgery and disorders | 2021-2025 | 81 | JP 3 | 98.07 |
| Ophthalmology and Visual Impairment Studies | 2021-2025 | 69 | JP 3 | 97.32 |
| Retinal Diseases and Treatments | 2021-2025 | 423 | JP 29 | 95.81 |
| Olfactory and Sensory Function Studies | 2021-2025 | 236 | JP 6 | 90.62 |
| Corneal Surgery and Treatments | 2021-2025 | 298 | JP 11 | 90.19 |
| Retinopathy of Prematurity Studies | 2021-2025 | 109 | JP 4 | 86.25 |
| Circadian rhythm and melatonin | 2021-2025 | 762 | JP 44 | 82.90 |
| Connexins and lens biology | 2021-2025 | 234 | JP 16 | 74.41 |
| Peroxisome Proliferator-Activated Receptors | 2021-2025 | 561 | JP 42 | 67.71 |
| Ocular Infections and Treatments | 2021-2025 | 732 | JP 29 | 64.57 |
